An Act relative to increasing access to epinephrine
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill aims to improve access to epinephrine auto-injectors, commonly known as EpiPens, for individuals at risk of severe allergic reactions. It seeks to lower the cost of these devices by encouraging manufacturers to offer more affordable options and by expanding access through various distribution channels. The legislation also intends to increase awareness about the importance of carrying epinephrine and knowing how to use it. Ultimately, the goal is to reduce the risk of serious health consequences from anaphylaxis.
Key provisions
- Encourages epinephrine manufacturers to offer lower-cost options.
- Expands access to epinephrine through pharmacies and other retail locations.
- Promotes awareness campaigns regarding the use of epinephrine auto-injectors.
- Requires schools and other institutions to have epinephrine available.
- Addresses barriers to access for uninsured and underinsured individuals.
Who is affected
- Individuals with allergies
- Parents of children with allergies
- Schools and educational institutions
- Pharmacies and retail stores
- Epinephrine manufacturers
Notable changes
- Potentially lowers the cost of epinephrine auto-injectors.
- Increases the availability of epinephrine in various settings.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
24 on record
Primary sponsor
House Committee on Ways and Means
Cosponsors
Carmine Lawrence Gentile
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours